Skip to main content
NORTHEAST PHARMACEUTICAL GROUP CO.,LTD logo

NORTHEAST PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 000597 ISIN · CNE0000009G0 LEI · 300300HX6JTMOEENF158 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,606 across all filing types
Latest filing 2025-04-02 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000597

About NORTHEAST PHARMACEUTICAL GROUP CO.,LTD

https://www.nepharm.com.cn

Northeast Pharmaceutical Group Co., Ltd. (NEPG) specializes in the research, development, manufacture, and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates as a large-scale integrated pharmaceutical enterprise with a diverse product portfolio encompassing vitamins, antibiotics, cardiovascular agents, and digestive system medications. NEPG is recognized as a global leader in the production of Vitamin C and Vitamin B1, alongside significant output in caffeine and fosfomycin. Its manufacturing facilities adhere to international quality standards, including Good Manufacturing Practice (GMP) certifications. The company serves a broad international market, exporting products to numerous countries while maintaining a strong domestic presence. NEPG focuses on technological innovation and industrial scaling to provide high-quality chemical raw materials and pharmaceutical preparations for global healthcare needs.

Recent filings

Filing Released Lang Actions
2024年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled '审计报告' which translates to 'Audit Report' and includes detailed audit opinions, audit basis, key audit matters, and responsibilities of management and auditors. It contains comprehensive financial statements such as consolidated balance sheets, income statements, cash flow statements, and notes to the financial statements for the fiscal year ending December 31, 2024. The presence of detailed audit procedures and auditor's opinion confirms this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters), indicating it is the full report, not just an announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR).
2025-04-02 Chinese
关于调整2025年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Dongbei Pharmaceutical Group Co., Ltd. regarding the adjustment of the estimated amount of daily related party transactions for the year 2025. It includes details about the nature of the transactions, the related parties involved, the approval process by the board and supervisory committee, and the opinions of independent directors. The document is a formal disclosure about related party transactions, which is a regulatory announcement typically required by stock exchanges to inform shareholders and the market about significant related party dealings. It does not contain financial statements or comprehensive financial data, nor is it a report like an annual or interim report. It is not a voting result, management change, or earnings release. The content fits best into a regulatory announcement category about related party transactions. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is about 5,389 characters, which is sufficient for a detailed announcement but not a full report.
2025-04-02 Chinese
关于拟续聘公司2025年度审计机构的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the proposed reappointment of the company's audit firm for the 2025 fiscal year. It details the audit firm's qualifications, independence, audit fees, and the approval process by the board and audit committee. It does not contain any actual audit report, financial statements, or audit results. The document is relatively short (2752 characters) and serves as a formal notice about the intention to reappoint the auditor, pending shareholder approval. Therefore, it is not an audit report itself but an announcement related to audit arrangements. According to the classification rules, such announcements about audit firm appointments or reappointments fall under Regulatory Filings (RNS) as they do not contain substantive audit report content.
2025-04-02 Chinese
独立董事候选人声明与承诺（黄永维）
Board/Management Information Classification · 95% confidence The document is a detailed declaration and commitment statement by an independent director candidate for a company's board. It includes statements of compliance with legal and regulatory requirements, qualifications, and independence criteria. There are no financial statements, earnings data, or report summaries. The content is related to board/management information, specifically about a director candidate's qualifications and commitments. Therefore, it fits best under the category of Board/Management Information (MANG). The document length and detail confirm it is not a brief announcement or a regulatory filing but a substantive declaration related to board management.
2025-04-02 Chinese
关于公司2024年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the company's 2024 profit distribution plan, including details on cash dividends per share, audited net profits, retained earnings, and compliance with stock exchange rules. It includes resolutions from the board and supervisory meetings and is dated April 3, 2025. The document is relatively short (2082 characters) and primarily serves to inform shareholders about the dividend distribution proposal rather than presenting a full financial report or detailed financial statements. This fits the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and related details for shareholders.
2025-04-02 Chinese
独立董事2025年第二次专门会议审核意见
AGM Information Classification · 95% confidence The document is a formal opinion from independent directors regarding various company proposals to be submitted to the shareholders' meeting, including profit distribution, auditor appointment, credit limits, guarantees, related party transactions, and accounting policy changes. It references compliance with stock exchange listing rules and company bylaws. The content is focused on reviewing and approving agenda items for a shareholders' meeting rather than presenting financial statements or detailed financial results. The document length is short (1893 characters) and it serves as an opinion or report related to governance and meeting agenda items. This fits best with the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2025-04-02 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.